Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Perspectum

New Analysis Shows Corrected T1 (cT1) Is the Most Appropriate Diagnosis and Monitoring Tool for Widespread Adoption of Resmetirom Treatment in the United States
From Perspectum
Via Business Wire
Major Study Shows Liver Health Measured with cT1 Predicts Clinical Outcomes
From Perspectum
Via Business Wire
New Multinational Study Shows MRI is Cost-Effective in the Diagnosis and Management of Steatotic Liver Disease
From Perspectum
Via Business Wire
Perspectum Awarded New FDA Grant to Evaluate Biomarker for Rare Disease Drug Development
From Perspectum
Via Business Wire
New Published Data Show Reproducibility and Utility of Perspectum’s MRI in Patients With Metabolic Liver Disease
From Perspectum
Via Business Wire
New Study Uncovers Unprecedented Links Between Liver and Heart Health and the Importance of Doctors' Prioritizing Liver Health to Promote Heart Health
From Perspectum
Via Business Wire
Perspectum Completes $19 Million Second Close of Series C Funding Led by Oppenheimer & Co. Inc. (“Oppenheimer”)
From Perspectum
Via Business Wire
Perspectum Completes $36 Million First Close of Series C Funding Led by Oppenheimer Holdings
From Perspectum
Via Business Wire
Perspectum and Nuance Collaborate to Scale Access to AI-Enabled Integrated Digital Care Platforms to Improve Patient Care for Metabolic Disease
From Perspectum
Via Business Wire
LiverMultiScan Shown to Be a Cost-Effective Alternative to Liver Biopsies for Monitoring Patients with Autoimmune Hepatitis
From Perspectum
Via Business Wire
Perspectum Announces American Medical Association (AMA) Issues Two Unique Category III CPT® Codes Priced Appropriately by the Centers for Medicare & Medicaid Services (CMS) for Noninvasive Biliary Anatomy Assessment With MRCP+
From Perspectum
Via Business Wire
LiverMultiScan® Detected Earlier Stages of Treatable Disease in Patients With Autoimmune Hepatitis to Allow Tailored Treatment
From Perspectum
Via Business Wire
LiverMultiScan Has Achieved Nationwide Payer Coverage for Diagnosis and Management of NAFLD and Other Established Chronic Liver Diseases
From Perspectum
Via Business Wire
First Patient Recruited for Multi-Year Collaborative Primary Sclerosing Cholangitis (PSC) Pediatric Study Using Perspectum’s Imaging Technology to Help Predict Disease Progression and Guide Patient Management
From Perspectum
Via Business Wire
Perspectum and HepQuant Announce Partnership to Bring a More Complete Picture of Liver Health
From Perspectum
Via Business Wire
New study finds Perspectum’s LiverMultiScan may positively impact patient participation in liver disease care pathways
From Perspectum
Via Business Wire
New Clinical Study Investigates Using Integrated Diagnostics to Enable Precision Medicine for Liver Cancer Patients
From Perspectum
Via Business Wire
Perspectum Files Registration Statement for Proposed Initial Public Offering
From Perspectum
Via Business Wire
New Partnership Between Marubeni/Clairvo and Perspectum to Bring LiverMultiScan to Japan
From Perspectum
Via Business Wire
New Study Shows Measurable Organ Impairment in Long COVID Patients
From Perspectum
Via Business Wire
Perspectum Appoints Annalisa Jenkins, MBBS, FRCP to Board of Directors
From Perspectum
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.